Open Targets Genetics Documentation
  • Introduction
  • Release notes
  • Change log
  • FAQs
  • Future Plans
  • Licence
  • Citation
  • Terms of Use
  • Our Approach
    • Overview
    • Assigning Variants to Disease (V2D)
    • Assigning Variants to Genes (V2G)
    • Prioritising causal genes at GWAS loci (L2G)
    • Colocalisation analysis
    • Data Sources
      • Genetic Variation
        • FinnGen
      • Molecular Traits
        • Splice QTLs
      • Others
  • How To Use Open Targets Genetics starting with
    • A Gene
    • A Study (Trait)
    • Multiple Studies
    • A Variant
    • Introducing the Locus Plot
  • Technical Pipeline
    • What Technologies Do We Use?
    • GitHub Repositories
    • Pipeline schematic overview
  • Meetings
    • ESHG Workshop 2019
    • ASHG Workshop 2018
  • Data access
    • Data Download
    • GraphQL API
Powered by GitBook
On this page

Future Plans

PreviousFAQsNextLicence

Last updated 2 years ago

There are some of the new functionalities and data coming up in future releases of Open Targets Genetics:

  • Tissue/SNP enrichment across diseases and traits (CHEERS method)

  • Mendelian Randomisation (6 proteomic summary stat data)

  • Tissue/trait-specific ‘Locus to Gene’ score

  • Therapeutic-area specific profiles (e.g. only include functional data relevant to immune-related disease in variant-to-gene assignment/scoring)

  • PheWAS based on rare variants

In the meantime, the team is working on refactoring Open Targets Genetics pipelines, aiming to:

  • Re-focusing the product around Target ID

  • Creating a gold standard toolkit for post-GWAS analysis

  • Faster/robust addition of new datasets and datatypes

  • Reducing computational and financial cost

Please see for more information.

To be informed of future updates, follow Open Targets on and , and keep an eye on the and .

this repository
Twitter
LinkedIn
Open Targets Blog
Open Targets Community